Home › Funds › Hudson Capital Management LLC › REGN

Hudson Capital Management LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Hudson Capital Management LLC reported holding 8,443 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$6.4M, representing 1.58% of its reported portfolio and ranking #27 among its reported holdings. Hudson Capital Management LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)8.44K sh
Reported value held$6.40M
Portfolio Weight1.58%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hudson Capital Management LLC's REGN position evolved

Hudson Capital Management LLC first disclosed a stake in REGN in Q3 2023 at 4,815 shares (US$4.0M). The position peaked in Q3 2026 at 8,443 shares, worth US$6.4M. Across 13 filings, Hudson Capital Management LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 8,443 shares valued at US$6.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.82K $3.96M New
Q4 2023 4.78K $4.20M Reduce
Q1 2024 4.64K $4.47M Reduce
Q2 2024 4.73K $4.97M Add
Q3 2024 4.60K $4.84M Reduce
Q4 2024 4.96K $3.53M Add
Q1 2025 5.46K $3.46M Add
Q2 2025 6.11K $3.21M Add
Q3 2025 7.40K $4.16M Add
Q4 2025 7.81K $6.03M Add
Q1 2026 8.26K $6.38M Add
Q2 2026 8.45K $5.27M Add
Q3 2026 8.44K $6.40M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Hudson Capital Management LLC held REGN?

Hudson Capital Management LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hudson Capital Management LLC's current position in REGN?

As of Q3 2026, Hudson Capital Management LLC holds 8.44K shares of REGN (REGENERON PHARMACEUTICALS), valued at $6.40M, representing 1.58% of its reported portfolio and ranking #27.

Has Hudson Capital Management LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), Hudson Capital Management LLC held unchanged its position in REGN. The position peaked in Q3 2026 at 8.44K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.